Kimia Biosciences Limited
About
Overview
Vision & Mission
Our Future
Our achievements
Team
Infrastructure
Quality
Facilities
Research & Developments
Products
APIs
Intermediates
Formulations
Investor Relations
Composition of BOD & Committees
Statutory Communication
2022
2021
2020
2019
2018
2017
2016
Annual Reports
Quarterly Results
Shareholding Pattern
Code of Conduct
Corporate Governance
Investor Grievances
Policies
Scheme of Amalgamation
Drafts and Formats for KYC Updation
Careers
Life at Kimia
Job Openings
Training & Safety
Menu
About
Overview
Vision & Mission
Our Future
Our achievements
Team
Infrastructure
Quality
Facilities
Research & Developments
Products
APIs
Intermediates
Formulations
Investor Relations
Composition of BOD & Committees
Statutory Communication
2022
2021
2020
2019
2018
2017
2016
Annual Reports
Quarterly Results
Shareholding Pattern
Code of Conduct
Corporate Governance
Investor Grievances
Policies
Scheme of Amalgamation
Drafts and Formats for KYC Updation
Careers
Life at Kimia
Job Openings
Training & Safety
Search
Close
Our Future
We invest in the future
To get more accreditations and to become strong cGMP compliant pharma company
To have a partnership with top Generic companies across the globe
To become 150 Million USD worth of the company by 2025
To create a world class manufacturing and R&D facility to develop cost effective products of best quality